Abstract
Abstract. Magnesium may reduce the risk of lung cancer by affecting cell proliferation, inflammation and by preserving lung function; however, the results of epidemiological studies on the potential benefits of magnesium in lung pathology are inconclusive. We conducted this meta-analysis to investigate the association between magnesium intake and the risk of lung cancer. A total of 5 studies were extracted from PubMed, SCOPUS, and the Cochrane Review (to May 2018). These studies involved 58,5821 participants with 8,977 lung cancer cases. The pooled relative risk (RR) indicated a significant association between lung cancer incidence and magnesium intake (RR = 0.88, 95% CI = 0.79 to 0.98; p = 0.018). To investigate the cause of heterogeneity of these studies (I2 = 75.8%, p < 0.001), we performed a subgroup analysis which was affected by the mean dose of magnesium intake, where doses of magnesium intake lower than 300 mg/d significantly decreased lung cancer risk (RR = 0.83, 95% CI = 0.70 to 0.99; p = 0.034). Increasing magnesium intake doses to over 300 mg/d did not reduce the incidence of lung cancer (RR = 0.89, 95% CI = 0.78 to 1.01; p = 0.076). Our meta-analysis suggests that magnesium intake of less than 300 mg/d may have protective effects in lung cancer.
References
1 (2016) KRAS and the reality of personalized medicine in non-small cell lung cancer. Mol. Med. 22, 380–387.
2 (2016) Genomic heterogeneity of multiple synchronous lung cancer. Nat. Commun. 7, 13200.
3 (2019) Cancer statistics. CA Cancer J. Clin. 69, 7–34.
4 (2006) Genome-wide distribution of 8-oxoguanine correlates with the preferred regions for recombination and single nucleotide polymorphism in the human genome. Genome Res. 16, 567–575.
5 (2006) Dietary zinc, copper and selenium, and risk of lung cancer. Int. J. Cancer 120, 1108–1115.
6 (2010) Mineral Intake and lung cancer risk in the NIH-American Association of Retired Persons Diet and Health Study. Cancer Epidemiol. Biomarkers Prev. 19, 1976–1983.
7 (2005) Dietary iron, zinc, and calcium and the risk of lung cancer. Epidemiology 16, 772–9.
8 (2005) Interaction among heme iron, zinc, and supplemental vitamin C Intake on the risk of lung cancer: Iowa women’s health study. Nutr. Cancer 52, 130–137.
9 (2012) Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy. J. Control. Release 158, 286–92.
10 (2009) Magnesium, calcium and cancer. Magnes. Res. 22, 247–255.
11 (2007) Magnesium and neoplasia: from carcinogenesis to tumor growth and progression or treatment. Arch. Biochem. Biophys. 458, 24–32.
12 (2002) Magnesium-DNA interactions and the possible relation of magnesium to carcinogenesis. Irradiation and free radicals. Crit. Rev. Oncol. Hematol. 42, 79–91.
13 (2017) The involvement of Mg2+ in regulation of cellular and mitochondrial functions. Oxid. Med. Cell. Longev. 2017, 1–8.
14 (2010) Does a higher ratio of serum calcium to magnesium increase the risk for postmenopausal breast cancer? Med. Hypotheses 75, 315–8.
15 (2003) Possible roles of magnesium on the immune system. Eur. J. Clin. Nutr.. 57, 1193–7.
16 (1986) The role of calcium, magnesium, and zinc in carcinogenesis. Adv. Exp. Med. Biol. 206, 497–515.
17 (2001) Role of magnesium in genomic stability. Mutat. Res. 475, 113–21.
18 (2011) Magnesium and cancer: a dangerous liason. Magnes. Res. 24, 92–100.
19 (2005) Magnesium: The missing element in molecular views of cell proliferation control. Bioessays 27, 311–20.
20 (2005) Dietary magnesium and C-reactive protein levels. J. Am. Coll. Nutr. 24, 166–71.
21 (2005) Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 28, 1438–44.
22 (1994) Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sample. Lancet (London, England) 344, 357–62.
23 (2002) Magnesium deficiency increases oxidative stress in rats. Indian J. Exp. Biol. 40, 1275–9.
24 (1997) Magnesium deficiency enhances oxidative stress and collagen synthesis in vivo in the aorta of rats. Int. J. Biochem. Cell. Biol.. 29, 1273–8.
25 (2012) Magnesium intake and risk of colorectal cancer: a meta-analysis of prospective studies. Eur. J. Clin. Nutr. 66, 1182–1186.
26 (2016) Odds ratio, hazard ratio and relative risk. Metod. Zv. 13, 59–67.
27 (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–34.
28 (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088–101.
29 (2002) Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539–58.
30 (2008) Dietary magnesium and DNA repair capacity as risk factors for lung cancer. Carcinogenesis 29, 949–56.
31 (2018) Dietary magnesium and cardiovascular disease: A review with emphasis in epidemiological studies. Nutrients 10.
32 (2013) Calcium intake and lung cancer risk among female nonsmokers: A report from the Shanghai Women’s Health study. Cancer Epidemiol. Biomarkers Prev. 22, 50–57.
33 (2012) A comparison of micronutrient inadequacy and risk of high micronutrient intakes among vitamin and mineral supplement users and nonusers in Canada. J. Nutr. 142, 534–40.
34 (2011) Dietary supplement use is associated with higher intakes of minerals from food sources. Am. J. Clin. Nutr. 94, 1376–81.
35 (2018) Molecular mechanisms of the preventable causes of cancer in the United States. Genes Dev. 32, 868–902.
36 (2011) Dietary calcium and magnesium intake in relation to cancer incidence and mortality in a German prospective cohort (EPIC-Heidelberg). Cancer Causes Control 22, 1375–1382.
37 (2017) Dietary mineral intake and lung cancer risk: the Rotterdam Study. Eur. J. Nutr. 56, 1637–1646.